Home > Publications > Consensus > EURO NMD Endorsed Consensus > 273rd ENMC International workshop: Clinico-Sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27-29 October 2023

273rd ENMC International workshop: Clinico-Sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27-29 October 2023

Authors:

Werner Stenzel 1 , Andrew L Mammen 2 , Laure Gallay 3 , Marie-Therese Holzer 4 , Felix Kleefeld 5 , Olivier Benveniste 6 , Yves Allenbach 7 ; ENMC Antisynthetase Syndrome Study Group
Collaborators, Affiliations collapse
Collaborators

ENMC Antisynthetase Syndrome Study Group: Yves Allenbach 7 , Olivier Benveniste 7 , Jan Damoiseaux 8 , Sonye K Danoff 9 , Louise Diederichsen 10 , David Fiorentino 11 , Laure Gallay 3 , Margherita Giannini 12 , Marie-Therese Holzer 4 , Felix Kleefeld 5 , Lia Kolsters 13 , Ingrid Lundberg 14 , Andrew L Mammen 15 , Alain Meyer 12 , Ioanna Minopulou 16 , Corinna Preusse 17 , Tobias Ruck 18 , Jantima Tanboon 19 , Sarah L Tansley 20 , Werner Stenzel 21 , Yurdagul Uzunhan 22

Among the idiopathic inflammatory myopathies, patients harbouring an Antisynthetase syndrome exhibit a unique clinical picture, with characteristic signs such as myositis, interstitial lung disease, arthritis, rash, and/or fever. Characteristic morphological features on skeletal muscle biopsies differentiate Antisynthetase syndrome from other forms of myositis. Autoantibodies typically recognizing one of the members of the aminoacyl-tRNA synthetase family of proteins can be detected in the serum of such patients, with anti-Jo1 being most frequent. Until now, an international consensus definition of the Antisynthetase syndrome is lacking, hence this workshop has undertaken the task to inform about the clinical, morphological and autoantibody profiles of Antisynthetase syndrome. The authors also expand their aims by giving management and therapeutic strategies, and finally provide precise classification criteria for Antisynthetase syndrome.

01 Dec 2024

Neuromuscular Disord, volume 45, issue 104453, pages

Muscle Disease